The disulphate ester of ursodeoxycholyl-paminobenzoic acid (PABA-UDCA) was synthesised and compared with PABA-UDCA for its use in detection of intestinal bacteria. This compound, PABA-UDCA disulphate, had characters in common with PABA-UDCA in that it was deconjugated by cholylglycine hydrolase to release free PABA and bacteria that split glycocholic acid deconjugated PABA-UDCA disulphate. Further, in rat experiments urinary excretions of PABA were measured for six hours after oral administration of 15 mg PABA-UDCA disulphate. Ten control rats excreted (mean (SE) 188-2 (13-6) 
(4.7) Rg; clindamycin 40-9 (5.5) ig; p<0001).
By contrast with PABA-UDCA, PABA-UDCA disulphate was not actively absorbed from any part of the small intestine in everted gut sac experiments, and showed poor recovery from bile after its intraileal instillation in rats. This indicated that PABA-UDCA disulphate is a single pass type substance in the gut and its oral administration test reflects the sum of the activities of bacteria in the small intestine and colon. The disulphate was easily soluble in water and this allowed its application in an in vitro test involving PABA-UDCA disulphate incubation with intraperitoneal pus (PABA-UDCA disulphate incubation test) from patients with peritonitis. This test was carried out on six patients with peritonitis, and the severity of bacterial peritonitis was expressed quantitatively. From the results obtained PABA-UDCA disulphate was considered a good material to detect intestinal bacteria. (Gut 1993; 34: 823-828) To evaluate intestinal bacteria, clinical application of breath tests with 14C labelled glycocholate, '4C-D-xylose, glucose-H2, or lactulose H2 has been proposed. [1] [2] [3] [4] [5] [6] [7] These tests have flaws, however, because they need a radioisotopic material or special, expensive equipment for measurement. To solve these problems, we reported the use of a conjugate of ursodeoxycholic acid with p-aminobenzoic acid (PABA-UDCA) for the evaluation of intestinal microflora.8 9 In this article we report studies on the use of a disulphated derivative of PABA-UDCA for the detection of intestinal bacteria.
Materials and methods

SYNTHESIS OF THE PABA CONJUGATE OF UDCA DISULPHATE
Synthesis of PABA-UDCA was by the method described previously. 8 The disulphate ester of PABA-UDCA was prepared by a modification of the method of Goto and associates.'°To a solution of PABA-UDCA (1 0 g) in anhydrous pyridine (10 ml) was added chlorosulphonic acid (1-0 ml) in anhydrous pyridine (10 ml) with ice cooling and the solution was then heated overnight at 50°C. The resulting solution was poured into ice water, acidified with concentrated HCI, and extracted with n-butanol. The organic layer was washed with H20, dried over anhydrous Na2SO4, mixed with a few drops of concentrated NH40H, and evaporated in vacuo. The residue was chromatographed on a silica gel column with ethanol:ammonium hydroxide (9:1 v/v). The appropriate fractions were collected and evaporated, and the residue was crystalised from methanol-ethyl acetate to give 460 [10] [11] [12] [13] [14] [15] [16] [17] [18] (1 H, s)). The ammonium salt was dissolved in H20, adjusted to pH 9-5 with NaOH, and passed through a column of ion exchange resin (Diaion HP 20, Mitsubishi Chemical Industries, Japan) to give the sodium salt ofPABA-UDCA disulphate, which was used in the reported experiments. Figure 1 Tables II and III show Figure 3 shows the results of the urinary excretion of PABA for six hours after dosing for all groups of rats. No adverse effects were noted in the rats and no deaths occurred. The control group of rats excreted (mean (SE)) 188-2 (13-6) ,ug of PABA into urine. Significant (p<0001) Figure 4 shows the results of the active transport experiment, indicating that PABA-UDCA was actively absorbed from the distal side of the ileum whereas its disulphate was not absorbed from any part of the small intestine. In vivo, considerable PABA-UDCA was recovered from bile (32-6 (1-3)% (n=3)), whereas recovery of PABA-UDCA disulphate was poor (18 (0 2 Figure 5 shows urinary recovery of PABA after intracolonic instillation of PABA in human subjects. The maximal urinary excretion of PABA was found three or four hours after PABA instillation. Total recoveries of PABA during six hours after instillation were 37-7%, 49 5%, and 38 5% in patients 1, 2, and 3 respectively.
PABA-UDCA DISULPHATE INCUBATION TEST IN PATIENTS WITH PERITONITIS
PABA-UDCA disuiphate was easily soluble in assay solution with pH 5-6 sodium acetate buffer, whereas the maximal solubility of PABA- 
